Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!

被引：0
|
作者：
Koufakis, Theocharis [1 ]
Popovic, Djordje S. [2 ,3 ]
Papadopoulos, Christodoulos [4 ]
Giouleme, Olga [5 ]
Doumas, Michael [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54642, Greece
[2] Univ Novi Sad, Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[3] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[4] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Cardiol 3, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Gastroenterol & Hepatol Div,Med Sch, Thessaloniki, Greece
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2024年 / 25卷 / 02期
关键词：
MAFLD; cardiovascular risk; MACE; pharmacotherapy; NONALCOHOLIC STEATOHEPATITIS;
D O I：
10.1080/14656566.2024.2312239
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：123 / 126
页数：4
相关论文
共 50 条
  • [31] Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome
    Xu, Qiuyu
    Zhang, Jie
    Lu, Yan
    Wu, Ling
    ISCIENCE, 2024, 27 (02)
  • [32] Is Nonalcoholic Fatty Liver Disease Not a Risk Factor for Cardiovascular Disease: Not Yet Time for a Change of Heart
    Henson, Jacqueline B.
    Roden, Michael
    Targher, Giovanni
    Corey, Kathleen E.
    HEPATOLOGY, 2020, 71 (05) : 1867 - 1869
  • [33] Prevalence of diagnosed advanced liver fibrosis in high-risk population with metabolic-dysfunction associated fatty liver disease screened in diabetology using transient elastography
    Aubin, Adrien
    Maynard, Marianne
    Segrestin, Berenice
    Chouik, Yasmina
    Milot, Laurent
    Hervieu, Valerie
    Zoulim, Fabien
    Disse, Emmanuel
    Levrero, Massimo
    Caussy, Cyrielle
    JOURNAL OF HEPATOLOGY, 2023, 78 : S687 - S688
  • [34] Metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease: Which can better identify the populations with a high risk of cardiovascular disease?
    Yoshio, Sachiyo
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1097 - 1099
  • [35] Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
    Giovanni Alejandro Salgado Alvarez
    Samanta Mayanin Pinto Galvez
    Uriel Garcia Mora
    Ana Delfina Cano Contreras
    Cristina Durán Rosas
    Bryan Adrián Priego-Parra
    Arturo Triana Romero
    Mercedes Amieva Balmori
    Federico Roesch Dietlen
    Sophia Eugenia Martinez Vazquez
    Ines Osvely Mendez Guerrero
    Luis Alberto Chi-Cervera
    Raúl Bernal Reyes
    Leonardo Alberto Martinez Roriguez
    Maria Eugenia Icaza Chavez
    Jose Maria Remes Troche
    World Journal of Hepatology, 2022, (08) : 1633 - 1642
  • [36] Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
    Alvarez, Giovanni Alejandro Salgado
    Galvez, Samanta Mayanin Pinto
    Mora, Uriel Garcia
    Contreras, Ana Delfina Cano
    Rosas, Cristina Duran
    Priego-Parra, Bryan Adrian
    Romero, Arturo Triana
    Balmori, Mercedes Amieva
    Dietlen, Federico Roesch
    Vazquez, Sophia Eugenia Martinez
    Guerrero, Ines Osvely Mendez
    Chi-Cervera, Luis Alberto
    Bernal Reyes, Raul
    Roriguez, Leonardo Alberto Martinez
    Chavez, Maria Eugenia Icaza
    Troche, Jose Maria Remes
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (08) : 1633 - 1642
  • [37] Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
    Wen, Wen
    Li, Hong
    Wang, Chunyi
    Chen, Chen
    Tang, Jiake
    Zhou, Mengyun
    Hong, Xuwei
    Cheng, Yongran
    Wu, Qi
    Zhang, Xingwei
    Feng, Zhanhui
    Wang, Mingwei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [38] Associations between metabolic dysfunction-associated fatty liver disease and atherosclerotic cardiovascular disease
    Wen, Wen
    Fan, Hua
    Zhang, Shenghui
    Hu, Siqi
    Chen, Chen
    Tang, Jiake
    You, Yao
    Wang, Chunyi
    Li, Jie
    Luo, Lin
    Cheng, Yongran
    Zhou, Mengyun
    Zhao, Xuezhi
    Tan, Tao
    Xu, Fangfang
    Fu, Xinyan
    Chen, Juan
    Dong, Peng
    Zhang, Xingwei
    Wang, Mingwei
    Feng, Yan
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 368 (06): : 557 - 568
  • [39] Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
    Jeong, Seogsong
    Oh, Yun Hwan
    Choi, Seulggie
    Chang, Jooyoung
    Kim, Sung Min
    Son, Joung Sik
    Lee, Gyeongsil
    Kim, Won
    Park, Sang Min
    GUT AND LIVER, 2021, : 589 - 598
  • [40] Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
    Han, Eugene
    Lee, Yong-Ho
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Byung-Wan
    Kang, Eun Seok
    Cha, Bong-Soo
    Kim, Seung Up
    GUT AND LIVER, 2022, 16 (05) : 786 - 797
12345